Alcohol
Volume 43, Issue 7 , Pages 509-519 , November 2009

Neurobiological mechanisms contributing to alcohol–stress–anxiety interactions

  • Yuval Silberman

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Michal Bajo

      Affiliations

    • Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA
    • ,
  • Ann M. Chappell

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • Translational Center for the Neurobehavioral Study of Alcoholism, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Daniel T. Christian

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Maureen Cruz

      Affiliations

    • Committee on Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA
    • ,
  • Marvin R. Diaz

      Affiliations

    • Neuroscience Training Program, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Thomas Kash

      Affiliations

    • Department of Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA
    • ,
  • Anna K. Lack

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Robert O. Messing

      Affiliations

    • Ernest Gallo Clinic and Research Center, Department of Neurology, University of California San Francisco, Emeryville, CA 94608, USA
    • ,
  • George R. Siggins

      Affiliations

    • Molecular and Integrative Neurosciences Department, The Scripps Research Institute, La Jolla, CA 92037, USA
    • ,
  • Danny Winder

      Affiliations

    • Department of Molecular Physiology & Biophysics, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA
    • Center for Molecular Neuroscience, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA
    • J.F. Kennedy Center for Research on Human Development, Vanderbilt University School of Medicine, Nashville, TN 37232-0615, USA
    • ,
  • Marisa Roberto

      Affiliations

    • Committee on Neurobiology of Addictive Disorders, The Scripps Research Institute, La Jolla, CA 92037, USA
    • Pearson Center for Alcoholism and Addiction Research, The Scripps Research Institute, La Jolla, CA 92037, USA
    • ,
  • Brian A. McCool

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • Translational Center for the Neurobehavioral Study of Alcoholism, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • ,
  • Jeff L. Weiner

      Affiliations

    • Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • Translational Center for the Neurobehavioral Study of Alcoholism, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA
    • Corresponding Author InformationCorresponding author. Department of Physiology and Pharmacology, Wake Forest University, School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, USA. Tel.: +1-336-716-8692; fax: +1-336-716-8501.

Received 24 December 2008 ,Accepted 22 January 2009.

References 

  1. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, et al. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol. 2002;37:504–508
  2. Addolorato G, Caputo F, Capristo E, Janiri L, Bernardi M, Agabio R, et al. Rapid suppression of alcohol withdrawal syndrome by baclofen. Am. J. Med. 2002;112:226–229
  3. Aggleton JP, Burton MJ, Passingham RE. Cortical and subcortical afferents to the amygdala of the rhesus monkey (Macaca mulatta).. Brain Res. 1980;190:347–360
  4. Ariwodola OJ, Weiner JL. Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J. Neurosci. 2004;24:10679–10686
  5. Bajo M, Cruz MT, Siggins GR, Messing R, Roberto M. Protein kinase C epsilon mediation of CRF- and ethanol-induced GABA release in central amygdala. Proc. Natl. Acad. Sci. U.S.A. 2008;105:8410–8415
  6. Balleine BW, Killcross S. Parallel incentive processing: an integrated view of amygdala function. Trends Neurosci. 2006;29:272–279
  7. Becker HC, Hale RL. Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal “kindling”. Alcohol. Clin. Exp. Res. 1993;17:94–98
  8. Becker HC, Lopez MF. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol. Clin. Exp. Res. 2004;28:1829–1838
  9. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron. 2006;49:589–601
  10. Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin. Psychol. Rev. 2006;26:162–178
  11. Brunton L, Parker K, Lazo J, Buxton I, Blumenthal D. Goodman and Gilman's Pharmacological Basis of Therapeutics. 11 ed.. McGraw-Hill; 2005;
  12. Carboni E, Silvagni A, Rolando MT, Di Chiara G. Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J. Neurosci. 2000;20:RC102
  13. Cassell MD, Freedman LJ, Shi C. The intrinsic organization of the central extended amygdala. Ann. N.Y. Acad. Sci. 1999;877:217–241
  14. Chalmers DT, Lovenberg TW, Grigoriadis DE, Behan DP, De Souza EB. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 1996;17:166–172
  15. Cheun JE, Yeh HH. Noradrenergic potentiation of cerebellar Purkinje cell responses to GABA: cyclic AMP as intracellular intermediary. Neuroscience. 1996;74:835–844
  16. Choi DS, Wang D, Dadgar J, Chang WS, Messing RO. Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J. Neurosci. 2002;22:9905–9911
  17. Chu K, Koob GF, Cole M, Zorrilla EP, Roberts AJ. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 2007;86:813–821
  18. Colombo G, Addolorato G, Agabio R, Carai MA, Pibiri F, Serra S, et al. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox. Res. 2004;6:403–414
  19. Cosci F, Schruers KR, Abrams K, Griez EJ. Alcohol use disorders and panic disorder: a review of the evidence of a direct relationship. J. Clin. Psychiatry. 2007;68:874–880
  20. Davis LL, Trivedi M, Choate A, Kramer GL, Petty F. Growth hormone response to the GABAB agonist baclofen in major depressive disorder. Psychoneuroendocrinology. 1997;22:129–140
  21. Davis M, Rainnie D, Cassell M. Neurotransmission in the rat amygdala related to fear and anxiety. Trends Neurosci. 1994;17:208–214
  22. Day HE, Curran EJ, Watson SJ, Akil H. Distinct neurochemical populations in the rat central nucleus of the amygdala and bed nucleus of the stria terminalis: evidence for their selective activation by interleukin-1beta. J. Comp. Neurol. 1999;413:113–128
  23. Dumont EC, Mark GP, Mader S, Williams JT. Self-administration enhances excitatory synaptic transmission in the bed nucleus of the stria terminalis. Nat. Neurosci. 2005;8:413–414
  24. Eiler WJ, Seyoum R, Foster KL, Mailey C, June HL. D1 dopamine receptor regulates alcohol-motivated behaviors in the bed nucleus of the stria terminalis in alcohol-preferring (P) rats. Synapse. 2003;48:45–56
  25. Fadda F, Mosca E, Meloni R, Gessa GL. Suppression by progabide of ethanol withdrawal syndrome in rats. Eur. J. Pharmacol. 1985;109:321–325
  26. Fallon JH, Koziell DA, Moore RY. Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal cortex and entorhinal cortex. J. Comp. Neurol. 1978;180:509–532
  27. Flannery BA, Garbutt JC, Cody MW, Renn W, Grace K, Osborne M, et al. Baclofen for alcohol dependence: a preliminary open-label study. Alcohol. Clin. Exp. Res. 2004;28:1517–1523
  28. Fox HC, Bergquist KL, Hong KI, Sinha R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcohol. Clin. Exp. Res. 2007;31:395–403
  29. Fuchs RA, Feltenstein MW, See RE. The role of the basolateral amygdala in stimulus-reward memory and extinction memory consolidation and in subsequent conditioned cued reinstatement of cocaine seeking. Eur. J. Neurosci. 2006;23:2809–2813
  30. Funk CK, Zorrilla EP, Lee MJ, Rice KC, Koob GF. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry. 2007;61:78–86
  31. Georges F, Aston-Jones G. Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J. Neurosci. 2002;22:5173–5187
  32. Gilpin NW, Richardson HN, Koob GF. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008;32:1535–1542
  33. Grueter BA, McElligott ZA, Robison AJ, Mathews GC, Winder DG. In vivo metabotropic glutamate receptor 5 (mGluR5) antagonism prevents cocaine-induced disruption of postsynaptically maintained mGluR5-dependent long-term depression. J. Neurosci. 2008;28:9261–9270
  34. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 2006;111:855–876
  35. Heilig M, Koob GF. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007;30:399–406
  36. Hodge CW, Mehmert KK, Kelley SP, McMahon T, Haywood A, Olive MF, et al. Supersensitivity to allosteric GABA(A) receptor modulators and alcohol in mice lacking PKCepsilon. Nat. Neurosci. 1999;2:997–1002
  37. Hodge CW, Raber J, McMahon T, Walter H, Sanchez-Perez AM, Olive MF, et al. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 2002;110:1003–1010
  38. Holsboer F, Ising M. Central CRH system in depression and anxiety—evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol. 2008;583:350–357
  39. Hyytia P, Koob GF. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur. J. Pharmacol. 1995;283:151–159
  40. Kageyama K, Hanada K, Moriyama T, Imaizumi T, Satoh K, Suda T. Differential regulation of CREB and ERK phosphorylation through corticotropin-releasing factor receptors type 1 and 2 in AtT-20 and A7r5 cells.. Mol. Cell. Endocrinol. 2007;263:90–102
  41. Kang MH, Spigelman I, Olsen RW. Alteration in the sensitivity of GABA(A) receptors to allosteric modulatory drugs in rat hippocampus after chronic intermittent ethanol treatment. Alcohol. Clin. Exp. Res. 1998;22:2165–2173
  42. Kash TL, Nobis WP, Matthews RT, Winder DG. Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process. J. Neurosci. 2008;28:13856–13865
  43. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch. Gen. Psychiatry. 1997;54:313–321
  44. Kim Y, Park MK, Uhm DY, Chung S. Modulation of T-type Ca2+ channels by corticotropin-releasing factor through protein kinase C pathway in MN9D dopaminergic cells. Biochem. Biophys. Res. Commun. 2007;358:796–801
  45. Kliethermes CL. Anxiety-like behaviors following chronic ethanol exposure. Neurosci. Biobehav. Rev. 2005;28:837–850
  46. Koob GF. A role for GABA mechanisms in the motivational effects of alcohol. Biochem. Pharmacol. 2004;68:1515–1525
  47. Koob GF, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97–129
  48. Koob GF, Le Moal M. Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction. Nat. Neurosci. 2005;8:1442–1444
  49. Koob GF, Le Moal M. Addiction and the Brain Antireward System. Annu. Rev. Psychol. 2008;59:29–53
  50. Krettek JE, Price JL. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol. 1978;178:225–254
  51. Kushner MG, Abrams K, Borchardt C. The relationship between anxiety disorders and alcohol use disorders: a review of major perspectives and findings. Clin. Psychol. Rev. 2000;20:149–171
  52. Kushner MG, Abrams K, Thuras P, Hanson KL, Brekke M, Sletten S. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcohol. Clin. Exp. Res. 2005;29:1432–1443
  53. Kushner MG, Abrams K, Thuras P, Thuras P, Hanson KL. Individual differences predictive of drinking to manage anxiety among non-problem drinkers with panic disorder. Alcohol. Clin. Exp. Res. 2000;24:448–458
  54. Kushner MG, Sher KJ, Erickson DJ. Prospective analysis of the relation between DSM-III anxiety disorders and alcohol use disorders. Am. J. Psychiatry. 1999;156:723–732
  55. Lack AK, Ariwodola OJ, Chappel A, Weiner JL, McCool BA. Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala. Neuropharmacology. 2008;55:661–668
  56. Lack, A. K., Christian, D. T., Diaz, M. R., & McCool, B. A. Chronic ethanol and withdrawal effects on kainate receptor mediated excitatory neurotransmission in the rat basolateral amygdala. Alcohol. 43, 25–33.
  57. Lack AK, Diaz MR, Chappell A, DuBois DW, McCool BA. Chronic ethanol and withdrawal differentially modulate pre- and postsynaptic function at glutamatergic synapses in rat basolateral amygdala. J. Neurophysiol. 2007;98:3185–3196
  58. LeDoux JE. Emotional memory: in search of systems and synapses. Ann. N.Y. Acad. Sci. 1993;702:149–157
  59. Le Moal M, Koob GF. Drug addiction: pathways to the disease and pathophysiological perspectives. Eur. Neuropsychopharmacol. 2007;17:377–393
  60. Li H, Rogawski MA. GluR5 kainate receptor mediated synaptic transmission in rat basolateral amygdala in vitro. Neuropharmacology. 1998;37:1279–1286
  61. Li H, Weiss SR, Chuang DM, Post RM, Rogawski MA. Bidirectional synaptic plasticity in the rat basolateral amygdala: characterization of an activity-dependent switch sensitive to the presynaptic metabotropic glutamate receptor antagonist 2S-alpha-ethylglutamic acid. J. Neurosci. 1998;18:1662–1670
  62. Lin AM, Freund RK, Palmer MR. Ethanol potentiation of GABA-induced electrophysiological responses in cerebellum: requirement for catecholamine modulation. Neurosci. Lett. 1991;122:154–158
  63. Li Q, Wilson WA, Swartzwelder HS. Developmental differences in the sensitivity of spontaneous and miniature IPSCs to ethanol. Alcohol. Clin. Exp. Res. 2006;30:119–126
  64. Lopez MF, Becker HC. Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology (Berl.). 2005;181:688–696
  65. Lowery EG, Sparrow AM, Breese GR, Knapp DJ, Thiele TE. The CRF-1 receptor antagonist, CP-154,526, attenuates stress-induced increases in ethanol consumption by BALB/cJ mice. Alcohol. Clin. Exp. Res. 2008;32:240–248
  66. Marinelli PW, Funk D, Juzytsch W, Harding S, Rice KC, Shaham Y, et al. The CRF1 receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology (Berl.). 2007;195:345–355
  67. Marowsky A, Yanagawa Y, Obata K, Vogt KE. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron. 2005;48:1025–1037
  68. Mascagni F, McDonald AJ. Immunohistochemical characterization of cholecystokinin containing neurons in the rat basolateral amygdala. Brain Res. 2003;976:171–184
  69. McDonald AJ, Mascagni F. Immunohistochemical characterization of somatostatin containing interneurons in the rat basolateral amygdala. Brain Res. 2002;943:237–244
  70. Menard J, Treit D. Effects of centrally administered anxiolytic compounds in animal models of anxiety. Neurosci. Biobehav. Rev. 1999;23:591–613
  71. Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 1995;15:5439–5447
  72. Miller WR, Harris RJ. A simple scale of Gorski's warning signs for relapse. J. Stud. Alcohol. 2000;61:759–765
  73. Muller JF, Mascagni F, McDonald AJ. Postsynaptic targets of somatostatin-containing interneurons in the rat basolateral amygdala. J. Comp. Neurol. 2007;500:513–529
  74. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR. Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science. 2004;303:1512–1514
  75. North RA, Williams JT, Surprenant A, Christie MJ. Mu and delta receptors belong to a family of receptors that are coupled to potassium channels. Proc. Natl. Acad. Sci. U.S.A. 1987;84:5487–5491
  76. Nose I, Higashi H, Inokuchi H, Nishi S. Synaptic responses of guinea pig and rat central amygdala neurons in vitro. J. Neurophysiol. 1991;65:1227–1241
  77. Olive MF, Koenig HN, Nannini MA, Hodge CW. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 2002;72:213–220
  78. Olive MF, Mehmert KK, Messing RO, Hodge CW. Reduced operant ethanol self-administration and in vivo mesolimbic dopamine responses to ethanol in PKCepsilon-deficient mice. Eur. J. Neurosci. 2000;12:4131–4140
  79. Olive MF, Messing RO. Protein kinase C isozymes and addiction. Mol. Neurobiol. 2004;29:139–154
  80. Overstreet DH, Knapp DJ, Breese GR. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 2004;77:405–413
  81. Palchaudhuri MR, Wille S, Mevenkamp G, Spiess J, Fuchs E, Dautzenberg FM. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri—cloning, functional expression and tissue distribution. Eur. J. Biochem. 1998;258:78–84
  82. Panchenko VA, Glasser CR, Partin KM, Mayer ML. Amino acid substitutions in the pore of rat glutamate receptors at sites influencing block by polyamines. J. Physiol. 1999;520(Pt 2):337–357
  83. Phelix CF, Chen H, Trevino G, Lara JR, Liu G, Wayner MJ. Bicuculline sensitive depressor response to ethanol infusion into the lateral hypothalamus. Alcohol. 1999;19:177–185
  84. Piazza PV, Le Moal M. The role of stress in drug self-administration. Trends Pharmacol. Sci. 1998;19:67–74
  85. Porrino LJ, Crane AM, Goldman-Rakic PS. Direct and indirect pathways from the amygdala to the frontal lobe in rhesus monkeys. J. Comp. Neurol. 1981;198:121–136
  86. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl. Acad. Sci. U.S.A. 1994;91:8777–8781
  87. Rassnick S, Heinrichs SC, Britton KT, Koob GF. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Res. 1993;605:25–32
  88. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA. 1990;264:2511–2518
  89. Rizos Z, Ovari J, Leri F. Reconditioning of heroin place preference requires the basolateral amygdala. Pharmacol. Biochem. Behav. 2005;82:300–305
  90. Roberts AJ, Cole M, Koob GF. Intra-amygdala muscimol decreases operant ethanol self-administration in dependent rats. Alcohol. Clin. Exp. Res. 1996;20:1289–1298
  91. Roberts AJ, Heyser CJ, Cole M, Griffin P, Koob GF. Excessive ethanol drinking following a history of dependence: animal model of allostasis. Neuropsychopharmacology. 2000;22:581–594
  92. Roberts AJ, Phillips TJ, Belknap JK, Finn DA, Keith LD. Genetic analysis of the corticosterone response to ethanol in BXD recombinant inbred mice. Behav. Neurosci. 1995;109:1199–1208
  93. Roberto M, Madamba SG, Stouffer DG, Parsons LH, Siggins GR. Increased GABA release in the central amygdala of ethanol-dependent rats. J. Neurosci. 2004;24:10159–10166
  94. Roder S, Ciriello J. Innervation of the amygdaloid complex by catecholaminergic cell groups of the ventrolateral medulla. J. Comp. Neurol. 1993;332:105–122
  95. Sah P, Faber ES, Lopez De Armentia M, Power J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003;83:803–834
  96. Sajdyk TJ, Shekhar A. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminobutyric acid-A receptor blockade in the basolateral amygdala of rats. J. Pharmacol. Exp. Ther. 1997;283:969–977
  97. Sajdyk TJ, Shekhar A. Excitatory amino acid receptors in the basolateral amygdala regulate anxiety responses in the social interaction test. Brain Res. 1997;764:262–264
  98. Samson HH, Hodge CW, Erickson HL, Niehus JS, Gerhardt GA, Kalivas PW, et al. The effects of local application of ethanol in the n. accumbens on dopamine overflow and clearance. Alcohol. 1997;14:485–492
  99. Sanders SK, Shekhar A. Regulation of anxiety by GABAA receptors in the rat amygdala. Pharmacol. Biochem. Behav. 1995;52:701–706
  100. Santucci AC, Cortes C, Bettica A, Cortes F. Chronic ethanol consumption in rats produces residual increases in anxiety 4 months after withdrawal. Behav. Brain Res. 2008;188:24–31
  101. Siggins GR, Roberto M, Nie Z. The tipsy terminal: presynaptic effects of ethanol. Pharmacol. Ther. 2005;107:80–98
  102. Silberman Y, Shi L, Brunso-Bechtold JK, Weiner JL. Distinct mechanisms of ethanol potentiation of local and paracapsular GABAergic synapses in the rat basolateral amygdala. J. Pharmacol. Exp. Ther. 2008;324:251–260
  103. Sinha R, Li CS. Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications. Drug Alcohol Rev. 2007;26:25–31
  104. Sun N, Cassell MD. Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol. 1993;330:381–404
  105. Takahashi LK. Role of CRF(1) and CRF(2) receptors in fear and anxiety. Neurosci. Biobehav. Rev. 2001;25:627–636
  106. Thomas MJ, Beurrier C, Bonci A, Malenka RC. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 2001;4:1217–1223
  107. Tye KM, Stuber GD, de Ridder B, Bonci A, Janak PH. Rapid strengthening of thalamo-amygdala synapses mediates cue-reward learning. Nature. 2008;453:1253–1257
  108. Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002;26:1494–1501
  109. Walker DL, Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol. Biochem. Behav. 2002;71:379–392
  110. Walker DL, Davis M. Role of the extended amygdala in short-duration versus sustained fear: a tribute to Dr. Lennart Heimer. Brain Struct. Funct. 2008;213:29–42
  111. Washburn MS, Moises HC. Electrophysiological and morphological properties of rat basolateral amygdaloid neurons in vitro. J. Neurosci. 1992;12:4066–4079
  112. Watanabe Y, Ikegaya Y, Saito H, Abe K. Opposite regulation by the β-adrenoceptor-cyclic amp system of synaptic plasticity in the medial and lateral amygdala in vitro. Neurosci. 1990;71:1031–1035
  113. Watkins SS, Epping-Jordan MP, Koob GF, Markou A. Blockade of nicotine self-administration with nicotinic antagonists in rats. Pharmacol. Biochem. Behav. 1999;62:743–751
  114. Weiner JL, Valenzuela CF. Ethanol modulation of GABAergic transmission: the view from the slice. Pharmacol. Ther. 2006;111:533–554
  115. Weiss F, Ciccocioppo R, Parsons LH, Katner S, Liu X, Zorrilla EP, et al. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N.Y. Acad. Sci. 2001;937:1–26
  116. Willinger U, Lenzinger E, Hornik K, Fischer G, Schonbeck G, Aschauer HN, et al. Anxiety as a predictor of relapse in detoxified alcohol-dependent patients. Alcohol Alcohol. 2002;37:609–612
  117. Woodruff AR, Sah P. Networks of parvalbumin-positive interneurons in the basolateral amygdala. J. Neurosci. 2007;27:553–563

PII: S0741-8329(09)00059-7

doi: 10.1016/j.alcohol.2009.01.002

Alcohol
Volume 43, Issue 7 , Pages 509-519 , November 2009

Article Tools